Global Investigative Journalism Network (https://archive.gijn.org/category/gijn-2/page/11/)
Don’t miss GIJN’s first webinar with BBC’s top online sleuth Paul Myers on May 22 at 10am EST. Myers, a favourite at GIJN’s conferences and an expert in online investigative research, will spend an hour sharing effective techniques in using Google and social media for digging up information on people of interest. And you’ll have a chance to ask him questions. Sign up now!
The COVID-19 pandemic narrative is dominated by numbers — mountains of data and seemingly endless statistical models. Yet most of the figures are uncertain at best, often highly flawed and simply untrue at worst. How to deal with the many claims on the truth that are made every day? What should journalists do if the evidence is poor?
During the pandemic, African countries have received hundreds of billions of dollars in loans and grants from global financial institutions, humanitarian agencies, and donor countries, to tackle the global health crisis. In this second Africa-focused GIJN webinar, Following the COVID-19 Money in Africa, three experts from Africa will share their insights on how they are keeping tabs on government budgets.
Authoritarianism is on the rise around the world, from failing democracies to despotic regimes. In this global GIJN webinar, we bring together four extraordinary journalists from Russia, Egypt, South Africa, and the Philippines to share strategies for staying effective and true to the journalism profession’s highest standards.
The COVID-19 pandemic, already highly complex, is made even more difficult to report by the proliferation of misinformation about drugs, cures, death rates and more. In this webinar, Reporting COVID-19 Disinformation, two veteran journalists will share their tips and strategies for dealing with the flood of bad information.
The global pandemic is producing a tsunami of data, and getting a grip on all the numbers is essential. Data journalism can not only fill out an incomplete story but also reveal hidden issues, and it’s critical to be able to analyze published data, find new data sources and understand how to work with the numbers. GIJN’s latest webinar, Digging into the Data, part of our series Investigating the Pandemic, offers cutting-edge tips from two leading data journalism experts.
GIJN is pleased to introduce its first webinar in a series of free hour-long programs on COVID-19, featuring three veteran journalists: Gloria Riva, who covers health and business for Italy’s weekly l’Espresso, is reporting from the epicentre of one of the worst-hit countries; Joey Qi, GIJN’s Chinese editor, has chronicled the resurgence of investigative stories coming out of China and what journalists everywhere can learn from their experience; and Drew Sullivan, editor-in-chief of the Organized Crime and Corruption Reporting Center, is focused on how criminal groups and corrupt officials may benefit from the pandemic.
We are six months into the COVID-19 crisis, and this global pandemic is far from over. To mark this milestone, GIJN is pleased to offer its 18th webinar in our series Investigating the Pandemic. Where Do We Go From Here? – New Avenues for Investigative Reporting on the Pandemic will reflect on what investigative journalism has achieved so far and what challenges lie ahead.
In this GIJN webinar, Surviving as a Freelance Journalist, we bring together five senior investigative journalists, four with hard-won years of freelance experience and one who has commissioned and worked with freelancers and independents for decades. They will suggest concrete steps to improve conditions for freelance investigative reporters, and share the best services and resources.
GIJN’s webinar “Behind the COVID-19 Vaccine Race” is the second event to mark the publication of our new guide, “Investigating Health and Medicine.” In this webinar, we are pleased to present a noted physician specializing in vaccine development and an award-winning health journalist. Together, they will cut through the fog to show what red flags to look for both before and after a vaccine is approved.